Vienna, VA (August 13, 2018) — B. Kelly Han, MD, is the recipient of the inaugural 2018 DeHaan Award for Innovation in Cardiology, which includes a $200,000 grant.

PARIS, May 22, 2018 — HeartFlow, Inc. today announced new data from the PACIFIC trial showed that the HeartFlow Analysis had the highest diagnostic performance for detecting coronary artery disease (CAD), the most common form of heart disease, when compared to other commonly used non-invasive cardiac tests.

An expert consensus document published May 2 in the Journal of the American College of Cardiology offers recommendations for limiting radiation exposure to both patients and medical personnel during cardiovascular imaging procedures.

MR angiography (MRA) is a relatively new alternative to CT angiography (CTA) for the evaluation of suspected pulmonary embolism (PE) and it even has one major advantage over CTA: it does not expose patients to ionizing radiation.

In 2017, Anthem implemented a new policy that requires outpatient MR and CT scans not considered medically necessary to be completed at a freestanding imaging facility to receive coverage. This went into effect in several states, sparking its fair share of controversy along the way, and a team of Boston-based researchers wanted to know how such a policy could impact patient care in Massachusetts.

REDWOOD CITY, Calif., March 1, 2018 — HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles for AutoPlaque technology, a software tool used to detect and characterize coronary artery plaque based on coronary computed tomography angiography (CCTA) images.

Cardiologists are receiving more exposure to different imaging modalities during their fellowships, but their job prospects and training vary widely. A more comprehensive and multimodality training approach could lead to better results.